Deacylated tRNA Accumulation Is a Trigger for Bacterial Antibiotic Persistence Independent of the Stringent Response by Wood, Whitney N. et al.
Chapman University 
Chapman University Digital Commons 
Biology, Chemistry, and Environmental Sciences 
Faculty Articles and Research 
Science and Technology Faculty Articles and 
Research 
6-15-2021 
Deacylated tRNA Accumulation Is a Trigger for Bacterial 
Antibiotic Persistence Independent of the Stringent Response 




Follow this and additional works at: https://digitalcommons.chapman.edu/sees_articles 
 Part of the Amino Acids, Peptides, and Proteins Commons, Bacteriology Commons, Biology 
Commons, and the Other Microbiology Commons 
Deacylated tRNA Accumulation Is a Trigger for Bacterial Antibiotic Persistence 
Independent of the Stringent Response 
Comments 
This article was originally published in mBio, volume 12, in 2021. https://doi.org/10.1128/mBio.01132-21 
Creative Commons License 
This work is licensed under a Creative Commons Attribution 4.0 License. 
Copyright 
The authors 
Deacylated tRNA Accumulation Is a Trigger for Bacterial
Antibiotic Persistence Independent of the Stringent Response
Whitney N. Wood,a* Kyle Mohler,b,c Jesse Rinehart,b,c Michael Ibbaa,d
aDepartment of Microbiology, The Ohio State University, Columbus, Ohio, USA
bDepartment of Cellular & Molecular Physiology, Yale School of Medicine, New Haven, Connecticut, USA
cSystems Biology Institute, Yale University, New Haven, Connecticut, USA
dSchmid College of Science and Technology, Chapman University, Orange, California, USA
ABSTRACT Bacterial antibiotic persistence occurs when bacteria are treated with an
antibiotic and the majority of the population rapidly dies off, but a small subpopula-
tion enters into a dormant, persistent state and evades death. Diverse pathways
leading to nucleoside triphosphate (NTP) depletion and restricted translation have
been implicated in persistence, suggesting alternative redundant routes may exist to
initiate persister formation. To investigate the molecular mechanism of one such
pathway, functional variants of an essential component of translation (phenylalanyl-
tRNA synthetase [PheRS]) were used to study the effects of quality control on antibi-
otic persistence. Upon amino acid limitation, elevated PheRS quality control led to
significant decreases in aminoacylated tRNAPhe accumulation and increased antibiotic
persistence. This increase in antibiotic persistence was most pronounced (65-fold
higher) when the relA-encoded tRNA-dependent stringent response was inactivated.
The increase in persistence with elevated quality control correlated with ;2-fold
increases in the levels of the RNase MazF and the NTPase MazG and a 3-fold reduc-
tion in cellular NTP pools. These data reveal a mechanism for persister formation in-
dependent of the stringent response where reduced translation capacity, as indi-
cated by reduced levels of aminoacylated tRNA, is accompanied by active reduction
of cellular NTP pools which in turn triggers antibiotic persistence.
IMPORTANCE Bacterial antibiotic persistence is a transient physiological state wherein
cells become dormant and thereby evade being killed by antibiotics. Once the anti-
biotic is removed, bacterial persisters are able to resuscitate and repopulate. It is
thought that antibiotic bacterial persisters may cause reoccurring infections in the
clinical setting. The molecular triggers and pathways that cause bacteria to enter
into the persister state are not fully understood. Our results suggest that accumula-
tion of deacylated tRNA is a trigger for antibiotic persistence independent of the
RelA-dependent stringent response, a pathway thought to be required for persist-
ence in many organisms. Overall, this provides a mechanism where changes in trans-
lation quality control in response to physiological cues can directly modulate bacte-
rial persistence.
KEYWORDS persistence, tRNA, translation
Bacterial persisters are a subpopulation of dormant microbial cells that are not activelygrowing or dividing, which causes them to be tolerant to bactericidal antibiotics (1).
Once the antibiotic reaches a low-enough concentration, persisters are able to resuscitate
and the bacterial population resumes growth, leading to infection relapse and chronic
bacterial infections (2). This mechanism of antibiotic-induced persisters is an example of
triggered persistence, one of two different types of bacterial persistence. Different triggers
that can cause bacterial cells to enter into a persistent state include antibiotics, amino acid
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starvation, immune factors, and other physiological stressors. Another type of persistence
is spontaneous, which occurs when a subpopulation of bacteria becomes dormant while
the vast majority of the bacterial culture are in the exponential phase of growth (3).
Persistence can be characterized by the observation that the majority of a bacterial culture
will be rapidly killed by exposure to an antibiotic while the subpopulation of persisters will
have a much lower rate of killing. These different responses to antibiotics by the persistent
and nonpersistent cells result in a biphasic killing curve that can be quantified by the mini-
mum duration of killing (4). Antibiotic persistence differs from both resistance and toler-
ance. Antibiotic resistance is when bacteria are able to actively grow in the presence of
antibiotics demonstrated by their elevated MIC for that antibiotic. Although antibiotic tol-
erance is similar to antibiotic persistence, the main difference is that tolerance affects the
entire population resulting in a lower killing rate than with nontolerant bacteria but with-
out any accompanying change in MIC (3, 4).
The health risk that persisters pose has caused them to receive considerable attention;
however, the mechanisms underlying how persisters form remain elusive (5). Since persisters
make up a small subpopulation of cells that have low biochemical activity, studying them
presents challenges. Much of our current understanding of persisters comes from selection
of high-persister mutants, those that display elevated levels of antibiotic tolerance, and from
screenings for persistence using knockout libraries and transcriptome analyses (6–9). Several
genes have been identified that might contribute to the dormant persister phenotype,
many of which are members of toxin/antitoxin (TA) module systems. These modules are
comprised of a stable toxin protein that when bound to the antitoxin forms an inactive com-
plex; in the absence of the antitoxin, critical cellular functions such as protein translation or
DNA replication are inhibited and cell growth is halted (1). One pathway to persister forma-
tion, via a TA module, involves the alarmone ppGpp. Several different external stressors can
induce the synthesis of ppGpp, which activates Lon protease. The Lon protease degrades
the antitoxin leading to inhibition of translation, slowing down cellular growth and increas-
ing antibiotic tolerance (10, 11). However, this model for persister formation has recently
been challenged, when it was shown that persister formation still occurs in an Escherichia
coli DrelA DspoT background that is unable to synthesize ppGpp (12, 13). Additionally,
another study has recently questioned the role of TA modules in persister formation (14).
This new model proposes that a drop in intracellular ATP concentration acts as a trigger for
persistence. This hypothesis proposes that a low concentration of ATP in the cell leads to a
decrease in the activities of key antibiotic targets such as protein synthesis, DNA replication,
cell wall biosynthesis, etc., leading to persistence (9, 12, 15). These results suggest that there
is not a single route to persister formation; rather, there may exist several redundant path-
ways, all of which can lead to persistence. However, the identities of these pathways, their
roles, and their possible connections to each other remain largely unclear.
Recently, several studies showed that perturbations in the protein synthesis machinery
have effects on bacterial persistence (16–22). Two of these studies involved the toxin
HipA, which can phosphorylate glutamyl-tRNA synthetase (GluRS), thereby inactivating it.
Aminoacyl-tRNA synthetases (aaRS) esterify amino acids to their cognate tRNA, and the
resulting aminoacyl-tRNA (aa-tRNA) forms a ternary complex with EF-Tu and GTP which is
then used as a substrate for ribosomal protein synthesis (23). When GluRS is inactivated
by HipA, it is unable to synthesize Glu-tRNAGlu, and the intracellular concentration of de-
acylated tRNAGlu increases. Deacylated tRNAGlu directly enters the A-site of the ribosome
which triggers the activation of RelA, a ppGpp synthase, and the stringent response is
turned on, which causes RelA-dependent bacterial persistence (16). It was recently shown
that HipA can also phosphorylate TrpRS and LysRS in addition to GluRS (21). Mutations in
the genes encoding IleRS, LeuRS, ProRS, and MetRS have also been found that caused an
increase in bacterial persistence. These mutations were identified in a DTA11 Escherichia
coli strain, which has all 10 type II TA modules and the hipBA locus deleted, indicating
that these persisters form via a different molecular mechanism than the one described
previously where a toxin led to translation inhibition (19). Antibiotics that target TrpRS
and LeuRS have also been used to study persistence in Chlamydia, which does not have
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the genes that encode RelA or SpoT and so does not appear to utilize the stringent
response (20, 24). The Chlamydia persisters form by a molecular mechanism similar to the
one described previously in which their trigger for persistence seems to be a direct effect
from slowing down translation via accumulation of deacylated tRNA but independent of
the stringent response.
Several studies have shown that the accuracy and efficiency of aminoacyl-tRNA syn-
thesis are critical determinants of bacterial homeostasis (25–27). To investigate how
this global role of aaRSs might impact persistence, mutations in pheS and pheT, which
encode the a-subunit and b-subunits of PheRS, respectively, were investigated in both
E. coli MG1655 relA1 and DrelA backgrounds. Changes were made in both the active
site and editing sites of PheRS to investigate the effects of varying aminoacylation effi-
ciency and accuracy, respectively. The PheRS editing site is used to clear misacylated
Tyr-tRNAPhe and m-Tyr-tRNAPhe. m-Tyr is a product of Phe oxidation and, in the absence
of PheRS editing, has been shown to be mistranslated, causing cytotoxicity and other
growth defects in E. coli (28, 29). PheRS quality control is also important beyond its pri-
mary role in maintaining translation accuracy, as demonstrated by the finding that
when m-Tyr-tRNAPhe is not hydrolyzed by PheRS, the stringent response is suppressed
(25). Changes in the active site of PheRS led to a significant decrease in the amount of
aminoacylated tRNAPhe in response to amino acid stress, and this also resulted in a sig-
nificant increase in antibiotic persistence but only in the strain that is unable to mount
the stringent response. These data indicate that disruption of bacterial homeostasis via
both reduced translation quality control and suppression of the stringent response to-
gether increases antibiotic persistence.
RESULTS
Changes in the active site of PheRS perturb discrimination against noncognate
amino acids. It has been previously shown that an editing-deficient PheRS E. coli vari-
ant, pheT G318W, had significant effects on cellular homeostasis under oxidative and
amino acid stress (25, 29). This strain is not able to edit Tyr-tRNAPhe or m-Tyr-tRNAPhe,
and consequently m-Tyr, a nonproteogenic amino acid, was shown to be incorporated
into the proteome and cause cytotoxicity (28, 29). This PheRS editing-deficient strain
was also shown to not activate the stringent response upon amino acid stress by m-Tyr
addition (25). Taken together, these previous findings provided a basis to investigate
the effects of PheRS quality control on bacterial antibiotic persistence and its depend-
ence on the stringent response.
Along with an E. coli PheRS editing-deficient strain, additional E. coli mutant strains
were made which chromosomally encode PheRS active site variants in both MG1655
relA1 and DrelA backgrounds (29–31). The two active site mutations that were made
on the E. coli chromosome encode the A294G and A294S variants in the a-subunit of
PheRS. The A294G replacement in the active site of PheRS is predicted to have reduced
amino acid substrate discrimination while the A294S replacement is predicted to have
increased discrimination (32). These replacements were also made in recombinant
E. coli PheRS to allow determination of the amino acid activation kinetics for the PheRS
active site variants (Table 1). The specificity of Phe-to-m-Tyr for wild-type (WT) PheRS is
22, and for aA294G PheRS, it is 1.8, confirming that editing is required to prevent misa-
cylated m-Tyr-tRNAPhe accumulation and that aA294G PheRS can only minimally
TABLE 1 Steady-state kinetics of amino acid activation by E. coliwild-type PheRS and two active site PheRS mutants
PheRS
Phe m-Tyr Tyra Specificity
Km (mM) kcat (s21) kcat/Km (s21/mM) Km (mM) kcat (s21) kcat/Km (s21/mM) kcat/Km (s21/mM) Phe/m-Tyr Phe/Tyr
WT 216 1 616 11 2.9 1756 31 236 3 0.13 0.0026 0.0004 22 1,400
aA294G 596 29 586 16 1.0 626 7 366 6 0.6 0.016 0.006 1.8 110
aA294S 276 7 976 10 3.6 NDa NDa 0.016 0.003 0.0016 0.0002 370 3,700
aIndividual kinetic parameters could not be determined due to a high Km and substrate solubility. kcat/Km was estimated by  = kcat/Km ([E][S]). Standard deviation is from 3
replicates. ND, not determined.
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discriminate between Phe and m-Tyr. In contrast, the specificity of Phe-to-m-Tyr for
aA294S PheRS is 370, indicating that this mutant is not able to efficiently activate m-
Tyr for aminoacylation. The same trend follows for the specificity of Phe-to-Tyr:
aA294G PheRS has a reduced substrate specificity compared to wild-type PheRS, and
aA294S PheRS has an increased specificity.
Bacterial antibiotic persistence increases when quality control is present, and
the stringent response is disrupted. To investigate if differences in noncognate sub-
strate discrimination by PheRS variants affect antibiotic persistence, minimum duration
of killing (MDK) assays were performed in both MG1655 relA1 and DrelA E. coli back-
grounds (see Fig. S1 in the supplemental material). The four different PheRS strains
(wild-type pheS/pheT, pheT G318W, pheS A294G, and pheS A294S) in both backgrounds
were grown to early log phase and then treated with 100mg/ml ampicillin for 3 h; each
hour, an aliquot was taken out, washed with sterile phosphate-buffered saline (PBS),
plated on LB plates, and incubated at 37°C overnight to calculate CFU. These assays
were performed in two different types of media. The first, medium A, is the control me-
dium which is a supplemented M9-based minimal medium that contains 40mg/ml of
all 20 proteogenic amino acids. The second, medium B, is the starvation medium which
is also a supplemented M9-based minimal medium that contains 40mg/ml of 18 pro-
teogenic amino acids, 10mg/ml Tyr, 40mg/ml m-Tyr, and no Phe. The total amounts of
persisters for wild-type PheRS, editing-deficient PheRS, and the two different active
site PheRS mutant strains in both E. coli backgrounds were calculated at the endpoint
after 3 h of exposure to ampicillin (Fig. 1). There was a significant increase in persisters
for pheS A294S in the DrelA background grown in medium B compared to all the other
PheRS strains that were tested. Three different variables were tested in this assay: relA
either present or knocked out, different pheT and pheS mutations, and nutrient limita-
tions. Each of the variables had an independent effect on persistence. For example, the
deletion of relA caused an increase in persistence when the other two variables
remained constant (compare solid blue bar and striped blue bar in WT pheS/pheT data
set in Fig. 1). When the three different variables are combined, deletion of relA, PheRS
quality control, and amino acid starvation, the effect on persistence is compounded
and the largest amount of persister cell formation is observed. These data indicate that
this pathway for bacterial antibiotic persistence is independent of the RelA-dependent
stringent response.
FIG 1 Antibiotic persistence increases when quality control is present, and the stringent response is
disrupted. Persistence assays were done with wild-type pheS/pheT, pheT G318W, pheS A294G, and pheS
A294S in both E. coli MG1655 relA1 (solid bars) and a XDrelA -36292-8262-3643 strain (striped bars).
Persistence was measured and quantified after 3 h of exposure to 100mg/ml ampicillin and is shown
on a log scale set relative to wild-type pheS/pheT in the relA1 background grown in medium A.
Medium A (blue) is a supplemented M9 minimal medium that contains 40mg/ml of all 20 proteogenic
amino acids, and medium B (green) is a supplemented M9 minimal medium with 40mg/ml of 18
proteogenic amino acids, 10mg/ml Tyr, 40mg/ml m-Tyr, and no Phe. Error bars represent standard
deviations from 3 biological replicates. WT pheS/pheT relA1 in medium A and medium B is significant to
pheS A294G DrelA in medium B with a P value of ,0.03. All data sets are significant to pheS A294S
DrelA in medium B with a P value of ,0.0001, except for pheS A294G DrelA in medium B with a P
valueof 0.0008. Statistical analysis was performed using two-way analysis of variance (ANOVA).
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A pheT G318W/pheS A294G double mutant was made in both the E. coli MG1655
relA1 and DrelA backgrounds. These strains would be able to synthesize, but not edit,
m-Tyr-tRNAPhe and Tyr-tRNAPhe and therefore would generate high levels of misacy-
lated tRNAPhe in the cell. The pheT G318W/pheS A294G double mutation allowed nor-
mal growth compared to the wild-type PheRS in medium A in both the relA1 and DrelA
backgrounds. However, we were not able to perform persister assays on the pheT
G318W/pheS A294G/DrelA mutant because the cells showed a substantial growth
defect in medium B (Fig. S2).
Levels of deacylated tRNAPhe correlate with the levels of persisters for the
active site mutants of PheRS. To investigate if there is a correlation between the lev-
els of persistence and the levels of deacylated tRNAPhe, assays were performed to quan-
tify tRNAPhe aminoacylation in all four PheRS strains in both relA1 and DrelA E. coli back-
grounds grown in either medium A or medium B (Fig. 2). A representative Northern
blot that was probed with a 32P-59-end-labeled oligonucleotide that is specific for
tRNAPhe is shown (Fig. 2A), and quantification from biological triplicates was performed
(Fig. 2B). Overall, there was no difference in the levels of aminoacylated-tRNAPhe across
all 4 different PheRS strains in the relA1 background grown in either medium A or me-
dium B. The only instances in which significantly decreased levels of aminoacylated-
tRNAPhe were observed were for the DrelA pheS A294G and DrelA pheS A294S mutant
strains grown in medium B, the same conditions that also gave rise to the highest
observed levels of persistence in this study.
Intracellular nucleotide concentrations indicate a reduction in metabolic activity
when persistence increases. The intracellular nucleotide concentrations were determined
by letting the wild-type pheS/pheT and all three mutants in both the relA1 and DrelA back-
grounds grow in medium A and medium B to early log phase. Metabolites were extracted
and then analyzed by liquid chromatography-mass spectrometry (LC-MS). There was a
FIG 2 Levels of aminoacylated tRNAPhe correlate with antibiotic persistence. (A) Representative Northern blots with a 32P-59-end-labeled tRNAPhe probe in
which 10mg total tRNA was separated by aminoacylated and deacylated tRNA species on an acid urea gel. For each strain, the left lane was grown in
medium A and the right lane was grown in medium B. Left panel is tRNA purified from the E. coli MG1655 relA1 strain, and right panel is tRNA purified
from the E. coli DrelA strain. (B) Percent aminoacylated tRNAPhe levels in vivo in wild-type pheS/pheT, pheT G318W, pheS A294G, and pheS A294S in both the
relA1 strain (left panel) and a DrelA strain (right panel). Cultures were grown to late log phase in either medium A (solid bars), which is a supplemented M9
minimal medium that contains 40mg/ml of all 20 proteogenic amino acids, or medium B (striped bars), which is a supplemented M9 minimal medium with
40mg/ml of 18 proteogenic amino acids, 10mg/ml Tyr, 40mg/ml m-Tyr, and no Phe. Error bars represent standard deviations from 3 biological replicates. *,
P value, 0.04; statistical analysis was performed using multiple t tests.
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general trend of having a lower intracellular nucleotide concentration in the strains that
showed elevated levels of persistence (Table 2), indicating a lower level of metabolic activity
in these cells. These strains all have quality control present, but their stringent response has
been disrupted. Bacterial antibiotic persister cells are able to evade killing by antibiotics
because they have a low metabolic state and antibiotics mostly target actively growing cells.
Also, the strains that resulted in very low levels of persistence had a higher intracellular con-
centration of ppGpp. The stringent response is activated by RelA in response to amino acid
stress by synthesizing the alarmone ppGpp, so these cells were able to respond to the nutri-
tional stress and did not enter into a persistent state. The highest levels of antibiotic persist-
ence that were observed were in the strains that have quality control present and are in the
DrelA background. This would indicate that these persister cells are independent of the pro-
duction of ppGpp. The editing-deficient mutant, pheT G318W, in the DrelA background
grown in medium B had elevated intracellular levels of AMP and GMP, indicative of ATP and
GTP hydrolysis compared to when this strain was grown in medium A. These data are
broadly inversely correlated with the changes in levels of persistence (Fig. 1), indicating that
when quality control is absent, the ability to enter into persistence is significantly reduced.
The active site mutant, pheS A294S, in the DrelA background grown in medium B
had the highest level of antibiotic persistence and also had a consistently lower nucle-
otide pool than the other pheS A294S strains. It was also observed that when the strin-
gent response is suppressed, which correlated with higher levels of persistence, there
is a lower concentration of the secondary messenger cyclic di-GMP. These data support
the idea that the strains that enter into antibiotic persistence have an overall lower in-
tracellular metabolite pool.
Proteome homeostasis is disrupted in strains that have a higher rate of antibiotic
persistence. Total proteome analyses were performed by using wild-type pheS/pheT and
pheS A294S strains in both the relA1 and DrelA backgrounds and grown in medium B to
mid-log phase. After the proteins were digested, the smaller peptides were injected for
LC-MS/MS analysis. There were a total of 2,351 proteins quantified across all samples
including PheS, PheT, and PheA. These 3 proteins either had no change or were slightly
overexpressed in the strains tested, which indicates that the expression of these proteins
has not been affected by our strain construction or growth conditions. Overall, proteome
homeostasis was disrupted for all strains compared to the wild-type pheS/pheT in the
relA1 background (see Fig. S3A to E and Data Set S1 in the supplemental materials).
Upon further investigation, we choose to focus the data analyses on the wild-type pheS/
pheT in the relA1 and DrelA background and pheS A294S in the DrelA background. The
differentially expressed proteins for wild-type pheS/pheT between relA1 and DrelA
TABLE 2 Intracellular nucleotide concentrationsa
ATP (mM) ADP (mM) AMP (mM) GTP (mM) GDP (mM) GMP (mM) Cyclic di-GMP (mM) ppGpp (mM)
WT pheS/pheT relA1-A 338 428 991 51 237 1,100 1.1 10
relA1-B 266 315 665 43 238 908 1.8 6.1
DrelA-A 238 219 245 32 117 265 0.5 2.8
DrelA-B 185 155 218 24 88 247 1.0 2.6
pheT G318W relA1-A 252 329 745 36 187 925 1.4 3.1
relA1-B 274 344 797 40 238 908 1.2 7.1
DrelA-A 243 225 175 31 126 201 0.7 2.2
DrelA-B 245 302 421 32 172 513 0.8 3.8
pheS A294G relA1-A 195 174 201 32 160 309 3.7 3.2
relA1-B 161 162 253 22 143 419 1.9 2.0
DrelA-A 206 187 229 26 109 244 0.6 2.3
DrelA-B 133 136 179 16 85 177 0.7 1.9
pheS A294S relA1-A 179 181 247 31 165 462 3.0 3.9
relA1-B 152 188 279 26 158 455 7.0 3.5
DrelA-A 194 176 234 25 116 289 0.4 1.9
DrelA-B 101 104 141 13 89 159 1.2 2.7
aBoth E. coliMG1655 relA1 and DrelA strains were grown in medium A (containing all 20 amino acids) and medium B (containing no Phe, a lower Tyr concentration, and
addedm-Tyr) for all 4 PheRS strains. Concentrations are an average from biological triplicates and experimental triplicates.
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(Table S1) and pheS A294S mutant in the DrelA background versus the wild-type pheS/
pheT in the relA1 background (Table S2) were used to develop a protein-protein interac-
tion (PPI) network (Fig. 3).
The PPI network showed several proteins that were differentially expressed in path-
ways for cellular amino acid biosynthesis, drug metabolism, and nucleotide
FIG 3 Protein homeostasis is disrupted during bacterial antibiotic persistence. Differential protein expression protein-protein interaction (PPI) network was
performed for wild-type pheS/pheT and pheS A294S in relA1 and DrelA backgrounds grown in medium B. The differentially expressed proteins are
represented by their fold change for either DrelA wild-type pheS/pheT versus relA1 wild-type pheS/pheT (inner ring) or DrelA pheS A294S versus relA1 wild-
type pheS/pheT (outer ring). The E. coli gene name is shown in the node, and cellular processes for amino acid biosynthesis (green), drug metabolism
(yellow), and nucleotide biosynthesis (pink) are highlighted. Edges are derived from previously determined protein-protein interactions within StringDB.
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biosynthesis (represented by the green, yellow, and pink nodes, respectively, in Fig. 3).
In general, the proteins involved in amino acid biosynthesis were downregulated in
the pheS A294S strains (represented by the outer ring in Fig. 3) and were either slightly
downregulated or had no change in the wild-type pheS/pheT (represented by the inner
ring in Fig. 3). These results are consistent with pheS A294S having a higher fraction of
persisters than the wild-type pheS/pheT in the DrelA background compared to the
relA1 background (Fig. 1). Strikingly, MazF and MazG were both enriched in all strains
compared to the wild-type pheS/pheT in the relA1 background. MazF is an RNase toxin
that comprises part of the MazEF toxin-antitoxin module which has been previously
studied in persister formation in E. coli (33, 34). MazG is a broad-specificity nucleoside
triphosphatase (NTPase) that modulates MazEF and is involved in regulating cell sur-
vival under amino acid starvation conditions (35, 36).
DISCUSSION
Aminoacyl-tRNA synthetase quality control is a determinant for antibiotic
persistence. Aminoacyl-tRNA synthetase quality control is important for accurate syn-
thesis of the proteome. When quality control is absent, misacylation of tRNAs can
occur, which was once thought to always be detrimental to the cell, but it is now
understood that in certain cases a low level of mistranslation can be beneficial for the
cell to adapt to a new or challenging environment (27, 37). It was previously observed
that when PheRS quality control is abolished by the use of a PheRS editing-deficient E.
coli strain, pheT G318W, the cells were not able to activate the stringent response (25).
The stringent response is critical for bacteria to withstand amino acid stress, and it is
activated when deacylated-tRNA enters the A-site of the ribosome which signals for
RelA to begin synthesizing the alarmone (p)ppGpp (38). When the PheRS editing-defi-
cient strain is grown under starvation conditions and in the presence of m-Tyr, a non-
proteogenic amino acid that is produced from the oxidation of Phe, misacylated m-
Tyr-tRNAPhe falsely inhibits the stringent response from being triggered because it
senses starvation via deacylated-tRNA and not misacylated-tRNA (25). The stringent
response has been thought to be a determinant for antibiotic persistence; however,
there have been a few studies where persistence has been shown to be stringent
response independent (12, 13, 20).
In this study, we have investigated the effects of PheRS quality control on bacterial
antibiotic persistence in E. coli. Along with the editing-deficient PheRS, we chose to
study two different active site PheRS mutants, aA294G and aA294S. It is assumed that
the aA294G mutation would have decreased substrate discrimination and the aA294S
mutation would have increased discrimination (32). The aA294G PheRS is unable to
discriminate between Phe and m-Tyr and has a 12.7-fold reduction in discrimination
for Tyr compared to wild-type PheRS. However, aA294S PheRS has a 16.8-fold increase
and a 2.6-fold increase of discrimination for m-Tyr and Tyr, respectively, compared to
wild-type PheRS (Table 1). With these kinetic data, it can be hypothesized that aA294G
PheRS will be able to efficiently synthesize m-Tyr-tRNAPhe; however, because editing is
intact, the misacylated m-Tyr-tRNAPhe will be moved into the editing site of PheRS
where it will be hydrolyzed (see Fig. S4A in the supplemental material). aA294G PheRS
also has decreased efficiency for phenylalanine adenylation, and so, in addition to
quality control, this mutant also fails to efficiently synthesize Phe-tRNAPhe, and this
would also contribute to increased levels of deacylated tRNAPhe. With the increased dis-
crimination of aA294S PheRS, it will not be able to synthesize m-Tyr-tRNAPhe (Fig. S4B).
In both of these scenarios, the amount of the intracellular deacylated tRNAPhe would
increase, and under starvation conditions, it would activate the stringent response.
Three different PheRS-encoding mutations, pheT G318W, pheS A294G, and pheS
A294S, were made on the chromosome of E. coli MG1655 and the corresponding DrelA
strain. Intriguingly, there was a reduction in persistence in the pheT G318W DrelA strain
grown under amino acid limitation (Fig. 1 and Fig. S1). In this strain, the misacylated
m-Tyr-tRNAPhe is not edited and so the stringent response is not triggered since the
amount of intracellular deacylated tRNAPhe does not change. This correlates with our
Wood et al. ®













































previous finding that when pheT G318W is unable to edit m-Tyr-tRNAPhe this resulted
in the stringent response being unable to be activated (25). These results seem to indi-
cate that when the intracellular concentration of deacylated tRNAPhe increases and a
stringent response is able to be mounted, the cell responds appropriately; however,
when RelA is not present, and the stringent response is disrupted, the cell can directly
enter into a persistent state.
Deacylated tRNA triggers antibiotic persistence independent of the stringent
response. Taken together, the kinetic data and the antibiotic persistence data suggest
that the intracellular level of deacylated tRNA may ultimately be a trigger for persist-
ence. To investigate this further, Northern blot analysis was performed on all 4 PheRS
strains in both the relA1 and DrelA E. coli background, which did confirm that the
amount of aminoacylated tRNAPhe significantly decreased in both pheS A294G and
pheS A294S in the DrelA background when grown in medium B (Fig. 2). This decrease
in aminoacylated tRNAPhe correlates with these two strains displaying the greatest per-
sistence. Our data support that the increase in persistence in the DrelA E. coli back-
ground is consistent with an increase in intracellular deacylated tRNAPhe concentra-
tions and is independent of the stringent response. We attempted to further
investigate persistence and the connection to deacylated tRNA accumulation using a
pheS A294G/pheT G318W double mutant, but this strain had a severe growth defect
when grown in medium B, and this growth defect was even more pronounced in the
DrelA background (Fig. S2).
Other studies have proposed that when aaRS activity is restricted or inhibited, the
amount of deacylated tRNA in the cell would increase and this may be the trigger for an-
tibiotic persistence, consistent with our data shown here (16, 20–22). In several previous
studies, it was shown that GluRS was inactivated by phosphorylation via the toxin HipA,
leading to limited tRNAGlu aminoacylation and increased levels of persistence. When this
occurs, the amount of deacylated tRNAGlu increases and it enters the A-site of the ribo-
some, triggering the stringent response via RelA; thus, this mechanism of persistence is
RelA dependent (16, 22). Interestingly, a few of these studies were conducted in bacteria
that lack RelA and have a disrupted stringent response. One study was conducted using
Chlamydia, a Trp auxotroph, and the authors used indolmycin to inhibit TrpRS, which led
to a decrease in aminoacylated tRNATrp that reduced translation rates and increased per-
sistence. Since Chlamydia does not encode RelA or SpoT, this mechanism of persistence
is stringent response independent (20). A few studies have been conducted in
Caulobacter crescentus, which relies solely on SpoT to regulate the stringent response
which requires both amino acid limitation and carbon or nitrogen starvation. In one
study, HipA was able to phosphorylate both GluRS and TrpRS, which inhibited their ami-
noacylation activity, and upon a further carbon or nitrogen stress, SpoT would synthesize
(p)ppGpp and the cells would enter into a persister state (21). In another study, the HipA
phosphorylation of TrpRS was further investigated, and it was found that as the levels of
Trp increase in the cell because it is not being used to aminoacylate tRNATrp, this led to
the inhibition of GlnE, which reduced the amount of glutamine production, creating a
nitrogen shortage. This imbalance in amino acids ultimately resulted in an increase in
persister cells that is SpoT dependent (39).
There has also been a recent study showing that defects in tRNA, such as a lack in
methylation, seem to have a link to antibiotic resistance and persistence (40, 41). In the
present study, the highest levels of persistence were associated with increased levels
of deacylated tRNAPhe and when RelA was deleted. SpoT is encoded in our DrelA
strains, accounting for our ability to detect ppGpp. In all the DrelA strains, ppGpp levels
remained steady regardless of amino acid limitation, suggesting that SpoT activity was
not significantly altered when persistence was increased.
Changes in metabolism reveal a cellular reprogramming in antibiotic persister
cells. Metabolomics and proteomics were performed in order to further understand
the metabolic state of the different strains that were used in this study. The metabolo-
mics data showed an overall trend of decreased intracellular concentrations of nucleo-
tides compared to the wild-type strain (Table 2). For example, the strain with the
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highest level of persistence, DrelA pheS A294S grown in medium B, had a reduced con-
centration of the nucleotides tested except for cyclic di-GMP and ppGpp compared to
the other pheS A294S strains. This is consistent with antibiotic persister cells having a
low biochemical and metabolic state because they are in a dormant, nongrowing
form. There was also a general trend of AMP and GMP having a higher intracellular
concentration compared to their di- and triphosphate purine nucleotides, which is also
consistent with persistent cells being in a low energetic state.
The proteomics data showed that cellular homeostasis was disrupted for wild-type
pheS/pheT and pheS A294S in the DrelA background compared to wild-type pheS/pheT
in the relA1 background when grown in medium B (Fig. 3). From the PPI network, it
was observed that most of the proteins that are involved in amino acid biosynthesis
were underrepresented compared to wild-type pheS/pheT in the relA1 background
which is consistent with the cells entering into a dormant state. Furthermore, from the
proteomics data PheA was overexpressed in pheS A294S in the DrelA background.
Expression of PheA is required for the biosynthesis of phenylalanine and is regulated
by transcription attenuation by the synthesis of the leader peptide PheL. Under normal
conditions, PheRS maintains the level of Phe-tRNAPhe for the attenuation of pheA tran-
scription (25, 42). However, pheS A294S in the DrelA background led to an increased
amount of deacylated tRNAPhe when grown in medium B, and this also led to the
increased expression of PheA, which further supports our model. Furthermore, PheA
had normal levels of expression when comparing the proteomics data of wild-type
pheS/pheT in the DrelA background compared to the relA1 background, indicating that
deletion of relA does not affect the transcription of pheA.
The toxin MazF was significantly enriched in both wild-type pheS/pheT and pheS
A294S in the DrelA background, and the antitoxin MazE was not detected above the
limit of detection. MazEF is a type II toxin-antitoxin module in which when the labile
antitoxin, MazE, is degraded in the cell MazF can cause toxicity by cleaving mRNA,
which may occur independent of translation (43). The regulator of the MazEF module,
MazG, was also upregulated. MazG is an NTP hydrolase that can cleave (p)ppGpp pro-
duced by RelA or SpoT and also hydrolyze the NTP substrates for the synthesis of (p)
ppGpp (35, 36). Since the upregulated MazG was observed in the DrelA background, it
could be hypothesized that the (p)ppGpp that MazG would be degrading is being pro-
duced from SpoT. It is also possible that MazG might be degrading NTPs to prevent
the synthesis of (p)ppGpp, since it was observed from the metabolomics that ATP and
GTP concentrations were reduced in these strains. Furthermore, to ensure that the
increase in the expression levels of MazF and MazG was not an artifact of transcrip-
tional read-through from the disruption of relA using a kanamycin cassette, sequencing
of this operon was performed (data not shown). We confirmed that both the 59
untranslated region (UTR) and 39 end of relA are intact and that the 59 region of mazEF,
which contains both of its promoters, was not disrupted by the kanamycin insertion
into the relA gene. Both of these promoters are required for the autoregulation of
mazEF, and when MazE is degraded, MazF is released as a toxin (44, 45). The promoter
for mazG was also not disrupted, which indicates that the increased levels of expres-
sion for both MazF and MazG are due to the cells having entered into an antibiotic per-
sister state. There were also changes in the levels of production for numerous proteins
involved in fatty acid synthesis, purine biosynthesis, and the tricarboxylic acid cycle,
which have previously been shown to be disrupted when bacterial persistence is trig-
gered (46–48). It should also be noted that for both the metabolomics and proteomics
experiments, the entire bacterial population was used for the metabolite and protein
extractions, so the quantifications are an average of the population. Since bacterial per-
sisters represent only a small fraction of the entire population (;1 to 10% in this
study), these subtle changes in the metabolite concentration and protein expression
may be more pronounced in the persister cell. Naturally occurring or spontaneous per-
sister cells occur at a frequency of ;1 1026, and mistranslation occurs every
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;1 1024 codons (27, 49). As these small frequencies in error begin to accumulate, so
the rate of bacterial persister formation increases.
Our data reveal a mechanism for persister formation where reduced translation
capacity is accompanied by accelerated depletion of cellular NTP pools, which in turn
triggers antibiotic persistence. Our data further show that the frequency of persister
formation via this mechanism is significantly influenced by the specificity and effi-
ciency with which substrates for translation are synthesized. While in our study
changes in PheRS specificity and efficiency were achieved via genetic manipulation,
nutrient depletion can also have comparable effects on aminoacyl-tRNA synthesis in
wild-type cells (50). This mechanism of bacterial persister formation is ppGpp inde-
pendent. Our study and several other studies have recently been challenging the role
of RelA and ppGpp in persister formation. Instead, changes in amino acid concentra-
tions, inhibition of aaRSs, and slowed translation are all mechanisms now known to be
able to induce bacterial antibiotic persistence. Taken together, these and previous find-
ings suggest that small amino acid imbalances, while not significantly impacting the
population as a whole, could lead to heterogenous quality control outcomes that
affect a small number of cells, thereby triggering the formation of a subpopulation of
antibiotic persisters.
MATERIALS ANDMETHODS
Strains, plasmids, and general methods. All strains were constructed in either a relA1 E. coli
(MG1655) background or a DrelA E. coli background (51). An editing-deficient PheRS E. coli strain, pheT
G318W, was previously made (25, 29). Two different mutant E. coli strains, pheS A294G and pheS A294S,
were constructed using scarless Cas9-assisted recombineering (no-SCAR) (30, 31). Briefly, pKDsgRNA-pheS
was made using round-the-horn cloning with pKDsgRNA-ackA, and primers for PCR were as follows: F-
sgRNA pheS, 59-ATCGACCCGGAAGTTTACTCGTTTTAGAGCTAGAAATAGCAAGTTAAAATAAGG-39, and PtetR,
59-PO4-GTGCTCAGTATCTCTATCACTGA-39. After pCas9Cr4 was chemically transformed into the host strain,
pKDsgRNA-pheS was transformed by electroporation. Colonies that contained both plasmids were grown
in super optimal broth medium with shaking at 30°C. When the optical density at 600nm (OD600) reached
0.1 to 0.2, l-red expression was induced with 0.2% arabinose. Once the culture reached an OD600 of 0.4 to
0.6, 2 mM single-stranded DNA (ssDNA) recombineering oligonucleotide that contained the desired
mutation was transformed by electroporation. The pheS A294G oligonucleotide sequence was 59-
AACGCAACATAGTCAGACGCTCCATCCCCATCCCAAACCCAAAACCGCTATAAACTTCGGGATCAATGCCAACGTT
ACGC-39, and the pheS A294S oligonucleotide sequence was 59-AACGCAACATAGTCAGACGCTCCATC
CCCATCCCAAAGCTAAAACCGCTATAAACTTCGGGATCAATGCCAACGTTACGC-39. Both recombineering oli-
gonucleotides had four phosphorothioate bonds at the 59 end of the oligonucleotide. Recombineering
occurred at 30°C for 2 h while shaking. Counterselection is achieved by induction of Cas9 with anhydrote-
tracycline. pKDsgRNA-pheS and pCas9Cr4 curing was performed exactly as described previously (31).
Clones were screened by colony PCR using forward primer 59-CTCGCAGAACTGGTTGCCAG-39 and reverse
primer 59-CACGCAGTTTGTCAGCGTTCG-39. Clones were confirmed by DNA sequencing using forward
primer 59-CTGATTGTTGATACCAACATC-39. E. coli XL1-Blue/pQE31-FRS (producing His6-tagged wild-type
PheRS) and E. coli XL1-Blue/pQE31-pheSA294G (producing His6-tagged aA294G PheRS) were previously
constructed (52). A point mutation was made in the pheS gene of pQE31-FRS by PCR-based site-directed
mutagenesis using two self-complementary primers (59-ACTCTGGTTTCAGCTTCGGGATGG-39) to generate
E. coli XL1-Blue/pQE31-pheSA294S (producing His6-tagged aA294S PheRS). The mutation was confirmed
by DNA sequencing. Protein expression and purification were performed essentially as described previ-
ously (53).
ATP/PPi exchange. Detailed description of the methods for ATP/PPi exchange to determine steady-
state kinetics of amino acid activation are in Text S1 in the supplemental material.
Growth medium. Lysogeny broth (LB) was made with 0.5% NaCl, 0.5% yeast extract, and 1% tryp-
tone. A supplemented M9 minimal medium that was used for persister assays was developed based on
a previous protocol (14). A 2 supplemented M9 minimal medium was prepared as follows: 2 M9 salts,
0.8% glucose, 4mM MgSO4, 0.2mM CaCl2, 2mg/ml thiamine, 1mg/ml FeSO4 solution, 80mg/ml all pro-
teogenic amino acids except for phenylalanine and tyrosine. For the persister assays, two different
media were used, medium A and medium B. Medium A contained 1 supplemented M9 minimal me-
dium, 40mg/ml phenylalanine, and 40mg/ml tyrosine. Medium B contained 1 supplemented M9 mini-
mal medium, 10mg/ml tyrosine, and 40mg/ml m-tyrosine (no phenylalanine was used in this medium).
Minimum duration of killing (MDK) persister assays. MDK persister assays were performed as
described in several studies (3, 4, 14, 54). Overnight cultures were grown in LB and were then diluted
1:100 into 6ml of either medium A or medium B in culture tubes. The cultures were grown at 37°C while
shaking at 250 rpm until they reached early exponential phase (OD600 = 0.2 to 0.3). At this point 1ml of
culture was taken out, serially diluted, and plated on LB plates to count CFU; 100mg/ml ampicillin was
added to the remaining culture; and growth continued at 37°C with shaking. Every hour for 3 h, 1ml of
culture was removed, washed in sterile phosphate-buffered saline (PBS) twice to remove the antibiotic,
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serially diluted, and plated on LB plates. To calculate persisters, the CFU of survivors after ampicillin
treatment was divided by the CFU of the culture before ampicillin treatment.
Quantification of aminoacylated and deacylated tRNA. Purification of total tRNA, acid/urea gel
electrophoresis, and Northern blotting methods are described in detail in Text S1.
Targeted metabolomic analysis and quantification. Metabolites were extracted from exponen-
tially growing E. coli cells as described previously (55, 56). Detailed methods for the metabolite extrac-
tion are described in Text S1.
LC-MS analysis of the metabolites was performed as described previously (57). The dried metabolites
were suspended in 50 ml of MilliQ water and centrifuged at 16,000 g for 30min at 4°C, and the super-
natant was transferred to an LC vial. Separation of metabolites was performed on a Thermo Scientific
UltiMate 3000 ultra-high performance liquid chromatography system equipped with a zwitter-ionic-
phosphorylcholine hydrophilic interaction liquid chromatography, 150- by 2.1-mm, 3-mm column with a
flow rate of 0.15ml/min and a column temperature of 37°C; mobile phase A was 10mM ammonium ace-
tate, pH 6, and mobile phase B was 10% 10mM ammonium acetate, pH 6, 90% acetonitrile.
Chromatography gradient was as follows: isocratic 100% mobile phase B for 3min, linear gradient to
20% B for 22min, linear gradient to 100% B for 1min, isocratic 100% B for 1min, linear gradient to 20%
B for 8min, linear gradient to 100% B for 5min, and isocratic 100% B for 15min. Standard curves with a
mixture of ATP, ADP, AMP, GTP, GDP, GMP, cyclic di-AMP, cyclic di-GMP, and ppGpp ranging from 0 to
5 ppm spiked with 10 ppm internal standard mix were done before and after each experimental set to
ensure column integrity. The MS was performed on a Thermo Scientific TSQ Quantiva (triple-stage quad-
rupole MS) with a spray voltage of 3,500 V in the negative ion mode, ion vaporizer at 50°C, and ion trans-
fer tube at 350°C. Analysis and quantification were performed using Xcalibur data acquisition and inter-
pretation software. Intracellular concentrations were calculated assuming an OD600 of 1.0 equals 8 108
cells and that the volume of one E. coli cell growing in exponential phase equals 1 10215 liter (58, 59).
This was then normalized by the extraction efficiency for [13C]ATP and [13C]GTP.
Protein digestion and mass spectrometry. (i) Digestion of intact E. coli for shotgun proteomics.
Twenty-milliliter cultures were inoculated to a starting OD at 600 nm of 0.01 in either medium A or me-
dium B using an overnight culture to stationary phase. After reaching mid-log, cells were chilled on ice
and pelleted by centrifugation for 2min at 8,000 rpm. The resulting pellet was frozen at280°C for down-
stream processing. For cell lysis and protein digest, cell pellets were thawed on ice and 2ml of cell pellet
was transferred to a microcentrifuge tube containing 40ml of lysis buffer (10mM Tris-HCl, pH 8.6, 10mM
dithiothreitol [DTT], 1mM EDTA, and 0.5% antilymphocyte serum [ALS]). Cells were lysed by vortex for
30 s, and disulfide bonds were reduced by incubating the reaction mixture for 30min at 55°C. The reac-
tion was briefly quenched on ice, and 16ml of a 60mM iodoacetamide solution was added. Alkylation of
cysteines proceeded for 30min in the dark. Excess iodoacetamide was quenched with 14ml of a 25mM
DTT solution, and the sample was then diluted with 330ml of 183mM Tris-HCl buffer (pH 8.0) supple-
mented with 2mM CaCl2. Proteins were digested overnight using 12mg sequencing-grade trypsin.
Following digestion, the reaction was then quenched with 12.5ml of a 20% trifluoroacetic acid (TFA) solu-
tion, resulting in a sample pHof,3. Remaining ALS reagent was cleaved for 15min at room temperature.
The sample (;30mg protein) was desalted by reverse-phase cleanup using C18 UltraMicroSpin columns.
The desalted peptides were dried at room temperature in a rotary vacuum centrifuge and reconstituted
in 20ml 70% formic acid-0.1% TFA (3:8 [vol/vol]) for peptide quantitation by UV280. The sample was
diluted to a final concentration of 0.4mg/ml, and 5ml (2mg) was injected for LC-MS/MS analysis.
(ii) Data acquisition and analysis. LC-MS/MS was performed using an Acquity UPLC M-class
(Waters) and Q Exactive Plus mass spectrometer. The analytical column employed was a 65-cm-long, 75-
mm-internal-diameter PicoFrit column (New Objective) packed in-house to a length of 50 cm with 1.9-
mm ReproSil-Pur 120-Å C18-AQ (Dr. Maisch) using methanol as the packing solvent. Peptide separation
was achieved using mixtures of 0.1% formic acid in water (solvent A) and 0.1% formic acid in acetonitrile
(solvent B) with a 90-min gradient of either 0/1, 2/7, 60/24, 65/48, 70/80, 75/80, 80/1, or 90/1 (min/% B,
linear ramping between steps). Gradient was performed with a flow rate of 250 nl/min. At least one
blank injection (5ml 2% B) was performed between samples to eliminate peptide carryover on the ana-
lytical column. One hundred femtomoles of trypsin-digested bovine serum albumin (BSA) or 100 ng
trypsin-digested wild-type K-12 MG1655 E. coli proteins was run periodically between samples as quality
control standards.The mass spectrometer was operated with the following parameters: (MS1) 70,000 re-
solution, 3e6 automatic gain control (AGC) target, 300 to 1,700 m/z scan range; (data-dependent MS2)
17,500 resolution, 1e6 AGC target, top 10 mode, 1.6 m/z isolation window, 27 normalized collision
energy, 90-s dynamic exclusion, unassigned, and 11 charge exclusion. Data were searched using
MaxQuant version 1.6.10.43 with deamidation (NQ), oxidation (M), and phospho (STY) as variable modifi-
cations and carbamidomethyl (C) as a fixed modification with up to 3 missed cleavages, 5-amino-acid
(aa) minimum length, and 1% false-discovery rate (FDR) against a UniProt E. coli database. Search results
were analyzed with Perseus version 1.6.2.2.
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